$TNXP·4

Tonix Pharmaceuticals Holding Corp. · Sep 29, 11:47 AM ET

Tonix Pharmaceuticals Holding Corp. 4

4 · Tonix Pharmaceuticals Holding Corp. · Filed Sep 29, 2015

Insider Transaction Report

Form 4
Period: 2015-09-28
GERSHELL LELAND
CFO and Treasurer
Transactions
  • Purchase

    Common Stock, $0.001 par value

    2015-09-28$5.83/sh+400$2,33019,260 total
Footnotes (1)
  • [F1]The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $5.825. The range of purchase prices on the transaction date was $5.82 to $5.83 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

Documents

1 file
  • 4
    v421226_4.xmlPrimary

    FORM 4